It has been demonstrated that the activation of the Nrf2 pathway significantly attenuates the progression of NAFLD by regulating antioxidant, anti-inflammatory and cytoprotective cellular responses [89]. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.